Albert et al. constructed nanobody-based monovalent and bivalent anti-EGFR TMs, which efficiently redirected UniCAR-T cells to recognize and lyse EGFR-positive tumor cells in vitro and in vivo. Here, EGFR is linked to neoplasm.